RYANODINE CONTRACTURE - A POTENTIALLY SPECIFIC INVITRO DIAGNOSTIC-TEST FOR MALIGNANT HYPERTHERMIA

被引:50
|
作者
HOPKINS, PM
ELLIS, FR
HALSALL, PJ
机构
关键词
HYPERTHERMIA; MALIGNANT; INVITRO TEST; PHARMACOLOGY; RYANODINE;
D O I
10.1093/bja/66.5.611
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
In vitro contracture tests used currently for malignant hyperthermia (MH) do not possess absolute specificity. This is potentially a great problem in the study of the genetic approach which offers the best prospect for the development of a non-invasive diagnostic test for the condition. The calcium release channel of the sarcoplasmic reticulum has been proposed as the site of the MH defect. Ryanodine, which binds avidly to this channel, was shown to differentiate between muscle of MH susceptible and normal patients in terms of in vitro contracture response. This ryanodine contracture response is proposed as a potentially specific in vitro diagnostic test for MH.
引用
收藏
页码:611 / 613
页数:3
相关论文
共 50 条
  • [21] INVITRO CONTRACTURE TESTING FOR DETERMINATION OF SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA - A METHODOLOGIC UPDATE
    IAIZZO, PA
    WEDEL, DJ
    GALLAGHER, WJ
    MAYO CLINIC PROCEEDINGS, 1991, 66 (10) : 998 - 1004
  • [22] NEUROLEPTIC MALIGNANT SYNDROME AND MALIGNANT HYPERTHERMIA - INVITRO COMPARISON WITH HALOTHANE AND CAFFEINE CONTRACTURE TESTS
    KRIVOSICHORBER, R
    ADNET, P
    GUEVART, E
    THEUNYNCK, D
    LESTAVEL, P
    BRITISH JOURNAL OF ANAESTHESIA, 1987, 59 (12) : 1554 - 1556
  • [23] Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine:: a comparative investigation in malignant hyperthermia
    Bendahan, D
    Guis, S
    Monnier, N
    Kozak-Ribbens, G
    Lunardi, J
    Ghattas, B
    Mattei, JP
    Cozzone, PJ
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (08) : 1019 - 1027
  • [24] EVALUATION OF NEW INVITRO DIAGNOSTIC-TEST PROCEDURES IN CLINICAL MICROBIOLOGY
    WASHINGTON, JA
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1989, 10 (02): : 77 - 79
  • [25] MALIGNANT HYPERTHERMIA DIAGNOSTIC DILEMMA - SHOULD THE COMBINED CAFFEINE HALOTHANE CONTRACTURE TEST BE USED ROUTINELY TO DIAGNOSE MH
    WEDEL, DJ
    NELSON, TE
    ANESTHESIOLOGY, 1993, 79 (3A) : A436 - A436
  • [26] Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test
    Roux-Buisson, N.
    Monnier, N.
    Sagui, E.
    Abriat, A.
    Brosset, C.
    Bendahan, D.
    Kozak-Ribbens, G.
    Gazzola, S.
    Quesada, J. -L.
    Foutrier-Morello, C.
    Rendu, J.
    Figarella-Branger, D.
    Cozonne, P.
    Aubert, M.
    Bourdon, L.
    Lunardi, J.
    Faure, J.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 116 (04) : 566 - 568
  • [27] Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations
    Fiege, M
    Wappler, F
    Weisshorn, R
    Gerbershagen, MU
    Steinfath, M
    Esch, JSA
    ANESTHESIOLOGY, 2002, 97 (02) : 345 - 350
  • [28] METARAMINOL PROVOCATIVE TEST - A SPECIFIC DIAGNOSTIC-TEST FOR FAMILIAL MEDITERRANEAN FEVER
    BARAKAT, MH
    GUMAA, KA
    ELKHAWAD, AO
    ELSOBKI, NI
    FENECH, FF
    LANCET, 1984, 1 (8378): : 656 - 657
  • [29] A COMPARISON OF SUCCINYLCHOLINE CONTRACTURE EFFECTS ON MALIGNANT HYPERTHERMIA DIAGNOSTIC HUMAN-MUSCLE
    KENNAMER, DL
    BELT, MW
    WINSETT, O
    NELSON, TE
    ANESTHESIOLOGY, 1986, 65 (3A) : A237 - A237
  • [30] Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: An experimental approach from a single laboratory
    Weisshorn, R
    Wappler, F
    Fiege, M
    Gerbershagen, MU
    Kolodzie, K
    Alberts, P
    Horn, EP
    Esch, JSA
    JOURNAL OF CLINICAL ANESTHESIA, 2004, 16 (05) : 353 - 357